MIAMI, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that...
Read moreNEW YORK, June 27, 2018 (GLOBE NEWSWIRE) -- Taglich Brothers, Inc. announces that it has initiated coverage of First Choice Healthcare Solutions,...
Read moreRolling BLA Submission Starting as Early as the End of 2018 - FDA Provides Guidance on Ongoing Requirements VANCOUVER, Washington,...
Read moreFRAMINGHAM, Mass., June 15, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of liquid, gel...
Read moreANAHEIM, CA, June 06, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions...
Read moreORLANDO, Fla., June 05, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Immune Therapeutics, Inc. (OTCQB:IMUN) ("Immune," “IMUN” or...
Read moreProstaGorx is the Ninth Innovus Pharma Product Approved in Canada to Date SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) --...
Read moreVANCOUVER, Washington, June 04, 2018 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY) announced today that results from a Phase 2b/3 trial...
Read moreMINNEAPOLIS, May 31, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence...
Read moreCoPrimers™ used in proof of concept evaluation SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a diagnostics company with a unique,...
Read moreMedian survival of top 100 patients is 40.5 months,Median survival of all 331 patients is 23.1 months, Longest survivors have...
Read moreBEVERLY, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for...
Read moreVideo News On PRECISION THERAPEUTICS, INC. - NASDAQ: AIPT https://youtu.be/G7Vc44qfBMQ About the STREAMWAY System Skyline's revolutionary, FDA-cleared STREAMWAY...
Read moreData Provide Support for PRO 140 as long-acting, HIV-1 maintenance therapy VANCOUVER, Washington, May 24, 2018 (GLOBE NEWSWIRE) -- CytoDyn...
Read moreATLANTA, GA, , May 24, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced...
Read moreMINNEAPOLIS, May 10, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence...
Read moreMINNEAPOLIS, May 08, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence...
Read moreSanta Monica, CA, May 01, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical...
Read moreMINNEAPOLIS, (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine...
Read moreORLANDO, Fla., April 26, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Immune Therapeutics, Inc. (OTCQB:IMUN) ("Immune" “IMUN” or the...
Read more